Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/NO2005/000434external-prioritypatent/WO2006054903A2/en
Application filed by Ge Healthcare AsfiledCriticalGe Healthcare As
Priority to NO20072988ApriorityCriticalpatent/NO20072988L/en
Publication of NO20072988LpublicationCriticalpatent/NO20072988L/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
Oppfinnelsen dreier seg om en metode for hjerteavbilding som gjør det mulig å bestemme levedyktigheten til celler i myokardium med hyperpolarisert 13C-pyruvat som MR-bildedanningsmiddel.The invention relates to a method of cardiac imaging that allows the viability of cells in myocardium to be determined with hyperpolarized 13C pyruvate as an MR imaging agent.
NO20072988A2004-11-192007-06-12
Method of cardiac imaging
NO20072988L
(en)
ELIGLUSTATE (GENZ 112638) AS A INHIBITOR OF GLUCOSYL CERAMIDE SYNTHESIS FOR USE IN A PROCEDURE FOR TREATING A FACTORY OR GAUCH'S DISEASE, WHICH METHOD OF METHODS INCLUDES THE ADMINISTRATION OF THE INDIVIDUAL